Related references
Note: Only part of the references are listed.Sequential Application of Anticancer Drugs Enhances Cell Death by Rewiring Apoptotic Signaling Networks
Michael J. Lee et al.
CELL (2012)
HMGA proteins promote ATM expression and enhance cancer cell resistance to genotoxic agents
D. Palmieri et al.
ONCOGENE (2011)
HMGA and Cancer
Monica Fedele et al.
BIOCHIMICA ET BIOPHYSICA ACTA-GENE REGULATORY MECHANISMS (2010)
The epidermal growth factor receptor modulates DNA double-strand break repair by regulating non-homologous end-joining
Malte Kriegs et al.
DNA REPAIR (2010)
Cetuximab and Chemotherapy as Initial Treatment for Metastatic Colorectal Cancer
Eric Van Cutsem et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
HMGA2 exhibits dRP/AP site cleavage activity and protects cancer cells from DNA-damage-induced cytotoxicity during chemotherapy
Heike Summer et al.
NUCLEIC ACIDS RESEARCH (2009)
HMGA1 is a molecular determinant of chemoresistance to gemcitabine in pancreatic adenocarcinoma
Siong-Seng Liau et al.
CLINICAL CANCER RESEARCH (2008)
Vascular endothelial growth factor receptor-1 contributes to resistance to anti-epidermal growth factor receptor drugs in human cancer cells
Roberto Bianco et al.
CLINICAL CANCER RESEARCH (2008)
Radiation-induced cell signaling: inside-out and outside-in
Kristoffer Valerie et al.
MOLECULAR CANCER THERAPEUTICS (2007)
Epidermal growth factor receptor and DNA double strand break repair: The cell's self-defence
Irena Szumiel
CELLULAR SIGNALLING (2006)
Handicapping the race to develop inhibitors of the phosphoinositide 3-kinase/Akt/mammalian target of rapamycin pathway
CA Granville et al.
CLINICAL CANCER RESEARCH (2006)
Multiple genetic and epigenetic interacting mechanisms' contribute to clonally selection of drug-resistant tumors: Current views and new therapeutic prospective
A Roberti et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2006)
Full activation of PKB/Akt in response to insulin or ionizing radiation is mediated through ATM
JG Viniegra et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Antitumor activity of ZD6474, a vascular endothelial growth factor receptor tyrosine kinase inhibitor, in human cancer cells with acquired resistance to antiepidermal growth factor receptor therapy
F Ciardiello et al.
CLINICAL CANCER RESEARCH (2004)
Analysis of relative gene expression data using real-time quantitative PCR and the 2-ΔΔCT method
KJ Livak et al.
METHODS (2001)
High mobility group I (Y) proteins bind HIPK2, a serine-threonine kinase protein which inhibits cell growth
GM Pierantoni et al.
ONCOGENE (2001)
Adenovirus-mediated suppression of HMGI(Y) protein synthesis as potential therapy of human malignant neoplasias
S Scala et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)
Share Paper
